Northern Trust
SER icon

Northern Trust’s Serina Therapeutics SER Stock Holding History

Northern Trust’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.3K Buy
+20,771
New +$39K ﹤0.01% 4298
2026
Q1 		– Sell
-14,082
Closed -$26.9K – 4550
2025
Q4 		$26.9K Sell
14,082
-455
-3% -$1.84K ﹤0.01% 4362
2025
Q3 		$77.9K Sell
14,537
-1,968
-12% -$10.5K ﹤0.01% 4190
2025
Q2 		$102K Sell
16,505
-506
-3% -$2.88K ﹤0.01% 4108
2025
Q1 		$96.5K Buy
17,011
+2,225
+15% +$10.5K ﹤0.01% 4124
2024
Q4 		$74.1K Sell
14,786
-1
-0% -$6 ﹤0.01% 4207
2024
Q3 		$98.9K Buy
+14,787
New +$117K ﹤0.01% 4060
2024
Q1 		– Sell
-897
Closed -$12.1K – 4495
2023
Q4 		$12.1K Hold
897
– – ﹤0.01% 4408
2023
Q3 		$21.4K Hold
897
– – ﹤0.01% 4322
2023
Q2 		$28.2K Hold
897
– – ﹤0.01% 4343
2023
Q1 		$20.9K Hold
897
– – ﹤0.01% 4442
2022
Q4 		$17.4K Hold
897
– – ﹤0.01% 4515
2022
Q3 		$18K Hold
897
– – ﹤0.01% 4564
2022
Q2 		$18K Hold
897
– – ﹤0.01% 4641
2022
Q1 		$27K Hold
897
– – ﹤0.01% 4639
2021
Q4 		$34K Hold
897
– – ﹤0.01% 4654
2021
Q3 		$30K Hold
897
– – ﹤0.01% 4591
2021
Q2 		$49K Sell
897
-2
-0.2% -$100 ﹤0.01% 4499
2021
Q1 		$51K Buy
899
+21
+2% +$1.47K ﹤0.01% 4381
2020
Q4 		$47K Hold
878
– – ﹤0.01% 4249
2020
Q3 		$25K Sell
878
-9
-1% -$321 ﹤0.01% 4186
2020
Q2 		$29K Sell
887
-5,124
-85% -$151K ﹤0.01% 4123
2020
Q1 		$197K Sell
6,011
-270
-4% -$12.7K ﹤0.01% 3689
2019
Q4 		$402K Sell
6,281
-333
-5% -$18K ﹤0.01% 3605
2019
Q3 		$456K Buy
6,614
+3,205
+94% +$304K ﹤0.01% 3562
2019
Q2 		$441K Buy
3,409
+340
+11% +$46K ﹤0.01% 3590
2019
Q1 		$438K Buy
3,069
+281
+10% +$41.1K ﹤0.01% 3575
2018
Q4 		$293K Buy
+2,788
New +$354K ﹤0.01% 3682

Other funds holding SER

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PSB
Piscataqua Savings Bank Portsmouth, New Hampshire $148M AUM 32.61% 1-Year Est. Return

Northern Trust's SER Position: Q2 2026 in Review

Northern Trust opened a new position in Serina Therapeutics (SER) in Q2 2026: 20,771 shares worth $40.3K. The stake represents ﹤0.01% of the portfolio and ranks #4298 among its holdings. This is a return to the name: Northern Trust previously reported a position in SER as recently as Q4 2025.

Northern Trust first reported a position in SER in Q4 2018 and has held it in 28 quarters since. The position peaked at $456K in Q3 2019. 21 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • Northern Trust held 20,771 shares of Serina Therapeutics worth $40.3K as of Q2 2026.
  • Serina Therapeutics was a new Northern Trust position in Q2 2026.
  • Serina Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4298 holding.
  • Northern Trust first reported a position in Serina Therapeutics in Q4 2018 and has held it in 28 quarters since.
  • Northern Trust's Serina Therapeutics position peaked at $456K in Q3 2019.
  • 21 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.